Ezetimibe combined with low-dose statin effectively lowers LDL in protease inhibitor treated patients.

Abstract

Ezetimibe (EZB) lowers cholesterol by blocking cholesterol absorption in the intestine. Data with EZB are limited in HIV-infected patients. We enrolled HIV-infected adults in this prospective, noncontrolled, single-center pilot study if their low-density lipoprotein (LDL) was not at goal despite therapy with a statin. Stable protease inhibitor (PI)-based… (More)
DOI: 10.1089/apc.2007.0206

Topics

2 Figures and Tables